High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$22K
$22,935
Total Sells (Filtered)
$3.6M
$3,587,957
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Discretionary Buy
|
2026-02-06 | $810 | P | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Discretionary Buy
|
2025-12-23 | $2,611 | P | Form 4 |
|
GALT
P
GALECTIN THERAPEUTICS INC
FREEMAN KEVIN D
• Director
Discretionary BuyΔOwn +11.1%
2025-12-23
$19,514
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Discretionary BuyΔOwn +11.1%
|
2025-12-23 | $19,514 | P | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-17
$45,500
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-17 | $45,500 | S | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-17
$31,532
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-17 | $31,532 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Other
2025-12-17
$14,219
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Other
|
2025-12-17 | $14,219 | M | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Other
2025-12-17
$21,250
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Other
|
2025-12-17 | $21,250 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-17
$59,840
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-17 | $59,840 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Equity Compensation
2025-12-17
$0
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Equity Compensation
2025-12-17
$0
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-12-17 | $22,391 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-12-17 | $55,241 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Other
|
2025-12-17 | $39,600 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -63.9%
2025-12-17
$139,303
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -63.9%
|
2025-12-17 | $139,303 | S | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -42.0%
2025-12-17
$33,121
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -42.0%
|
2025-12-17 | $33,121 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-12-16 | $204,335 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -42.9%
2025-12-15
$53,027
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -42.9%
|
2025-12-15 | $53,027 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Other
|
2025-12-15 | $35,015 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Equity Compensation
|
2025-12-12 | $0 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Shlevin Harold H.
• Director
10b5-1 SellΔOwn -63.9%
2025-12-12
$124,181
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
10b5-1 SellΔOwn -63.9%
|
2025-12-12 | $124,181 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
Director
Other
|
2025-12-12 | $82,339 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-12-03 | $687,600 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-12-02 | $164,100 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-18 | $55,638 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -78.7%
|
2025-11-18 | $174,866 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-18 | $20,213 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -70.5%
|
2025-11-18 | $113,321 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-18 | $16,211 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-18 | $41,723 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -23.4%
|
2025-11-17 | $14,012 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-17 | $37,475 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-17 | $94,643 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-17 | $18,980 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -55.7%
|
2025-11-17 | $57,820 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-17 | $21,868 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -72.1%
|
2025-11-17 | $118,831 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-17 | $2,857 | M | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Other
2025-11-13
$19,988
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Other
|
2025-11-13 | $19,988 | M | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Other
2025-11-13
$103,750
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Other
|
2025-11-13 | $103,750 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -90.3%
2025-11-13
$227,005
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -90.3%
|
2025-11-13 | $227,005 | S | Form 4 |
|
GALT
M
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
Other
2025-11-13
$91,300
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
Other
|
2025-11-13 | $91,300 | M | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -83.0%
2025-11-13
$119,612
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -83.0%
|
2025-11-13 | $119,612 | S | Form 4 |
|
GALT
S
GALECTIN THERAPEUTICS INC
Jamil Khurram
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -78.4%
2025-11-13
$88,888
|
||||||
| GALT |
GALECTIN THERAPEUTICS INC
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -78.4%
|
2025-11-13 | $88,888 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-11-11 | $210,000 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-10 | $3,722 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -19.8%
|
2025-11-10 | $11,321 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-10 | $1,859 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -18.0%
|
2025-11-10 | $10,095 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-10 | $2,135 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -18.6%
|
2025-11-10 | $10,468 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-10 | $4,462 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-10 | $11,252 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-05 | $478 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-05 | $396 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 Sell
|
2025-11-05 | $1,200 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-05 | $222 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-05 | $344 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-05 | $1,200 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-04 | $17,650 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-04 | $9,961 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -54.1%
|
2025-11-04 | $54,472 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-04 | $18,475 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -58.5%
|
2025-11-04 | $65,198 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-04 | $34,464 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-04 | $87,529 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -53.9%
|
2025-11-04 | $54,108 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -14.1%
|
2025-11-03 | $7,512 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-03 | $1,399 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-03 | $2,150 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -14.2%
|
2025-11-03 | $7,573 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -14.6%
|
2025-11-03 | $7,813 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-11-03 | $7,813 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-11-03 | $3,107 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-11-03 | $2,574 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-10-22 | $98,600 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
10% Owner
Discretionary Sell
|
2025-10-22 | $148,200 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
Other
|
2025-09-12 | $33,460 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CEO
10b5-1 Sell
|
2025-09-12 | $89,048 | S | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
Other
|
2025-09-12 | $11,927 | M | Form 4 |
| GALT |
GALECTIN THERAPEUTICS INC
|
CFO
10b5-1 SellΔOwn -53.4%
|
2025-09-12 | $56,054 | S | Form 4 |